\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand\HyField@AuxAddToFields[1]{}
\providecommand\HyField@AuxAddToCoFields[2]{}
\citation{ribas2018cancer}
\citation{topalian2015immune}
\citation{sharma2017primary}
\citation{yarchoan2017tumor}
\citation{patel2015pd}
\citation{samstein2019tumor}
\citation{stratigos2021european}
\citation{migden2018pd}
\citation{bonilla2016genomic}
\citation{davis1988t,rossjohn2015t}
\citation{robins2009comprehensive}
\citation{glanville2017identifying}
\citation{dash2017quantifiable}
\citation{zhang2018investigation}
\citation{robins2009comprehensive,mamedov2013preparing}
\citation{tumeh2014pd}
\citation{postow2015peripheral}
\@writefile{toc}{\contentsline {section}{\numberline {1}Introduction}{3}{section.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.1}Cancer Immunotherapy and Predictive Biomarkers}{3}{subsection.1.1}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.2}T-Cell Receptor Biology and Repertoire Analysis}{3}{subsection.1.2}\protected@file@percent }
\citation{greiff2015bioinformatic}
\citation{lecun2015deep}
\citation{dietterich1997solving}
\citation{ilse2018attention}
\citation{vaswani2017attention}
\citation{bahdanau2015neural}
\citation{sidhom2021deeptcr}
\@writefile{toc}{\contentsline {subsection}{\numberline {1.3}Deep Learning for TCR Repertoire Classification}{4}{subsection.1.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {1.4}Study Objectives}{4}{subsection.1.4}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {2}Methods}{5}{section.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.1}Study Design and Patient Cohort}{5}{subsection.2.1}\protected@file@percent }
\@writefile{lot}{\contentsline {table}{\numberline {1}{\ignorespaces \textbf  {Patient and Repertoire Characteristics}\relax }}{5}{table.caption.2}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{tab:patient_characteristics}{{1}{5}{\textbf {Patient and Repertoire Characteristics}\relax }{table.caption.2}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.2}TCR Sequencing and Data Processing}{5}{subsection.2.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {1}{\ignorespaces \textbf  {Data Processing Pipeline.} Overview of the complete analytical workflow from raw TCR sequencing data through quality control, feature encoding, and DeepTCR model training. The pipeline processed 239,637 productive TRB sequences from 34 patients for analysis.\relax }}{6}{figure.caption.3}\protected@file@percent }
\newlabel{fig:pipeline}{{1}{6}{\textbf {Data Processing Pipeline.} Overview of the complete analytical workflow from raw TCR sequencing data through quality control, feature encoding, and DeepTCR model training. The pipeline processed 239,637 productive TRB sequences from 34 patients for analysis.\relax }{figure.caption.3}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.3}Feature Engineering and Encoding}{6}{subsection.2.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.4}DeepTCR Architecture}{6}{subsection.2.4}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {2}{\ignorespaces \textbf  {DeepTCR Model Architecture.} The attention-based multiple instance learning framework processes individual TCR sequences through a convolutional encoder, integrates gene usage features, applies learned attention weights to identify important sequences, and aggregates to patient-level predictions.\relax }}{7}{figure.caption.4}\protected@file@percent }
\newlabel{fig:architecture}{{2}{7}{\textbf {DeepTCR Model Architecture.} The attention-based multiple instance learning framework processes individual TCR sequences through a convolutional encoder, integrates gene usage features, applies learned attention weights to identify important sequences, and aggregates to patient-level predictions.\relax }{figure.caption.4}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {2.5}Training Configuration}{7}{subsection.2.5}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.6}Monte Carlo Cross-Validation}{7}{subsection.2.6}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {2.7}Statistical Analysis}{8}{subsection.2.7}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {3}Results}{8}{section.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {3.1}Cohort Characteristics}{8}{subsection.3.1}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {3}{\ignorespaces \textbf  {Cohort Overview.} (A) Distribution of TCR sequences per patient by response status. (B) CDR3 length distribution across the cohort. (C) Summary of key cohort characteristics.\relax }}{9}{figure.caption.5}\protected@file@percent }
\newlabel{fig:cohort}{{3}{9}{\textbf {Cohort Overview.} (A) Distribution of TCR sequences per patient by response status. (B) CDR3 length distribution across the cohort. (C) Summary of key cohort characteristics.\relax }{figure.caption.5}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.2}Model Performance}{9}{subsection.3.2}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {4}{\ignorespaces \textbf  {Model Performance.} (A) Receiver operating characteristic (ROC) curve showing mean performance (solid line) with 95\% confidence band (shaded region) across 100 cross-validation folds. (B) Distribution of AUC values across folds, demonstrating consistent performance. (C) Summary statistics table.\relax }}{10}{figure.caption.6}\protected@file@percent }
\newlabel{fig:performance}{{4}{10}{\textbf {Model Performance.} (A) Receiver operating characteristic (ROC) curve showing mean performance (solid line) with 95\% confidence band (shaded region) across 100 cross-validation folds. (B) Distribution of AUC values across folds, demonstrating consistent performance. (C) Summary statistics table.\relax }{figure.caption.6}{}}
\@writefile{lot}{\contentsline {table}{\numberline {2}{\ignorespaces \textbf  {Model Performance Summary}\relax }}{10}{table.caption.7}\protected@file@percent }
\newlabel{tab:performance}{{2}{10}{\textbf {Model Performance Summary}\relax }{table.caption.7}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.3}Training Dynamics}{10}{subsection.3.3}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {5}{\ignorespaces \textbf  {Training Dynamics.} (A) Loss curves across training epochs showing convergence. (B) AUC progression during training. (C) Computational performance metrics.\relax }}{11}{figure.caption.8}\protected@file@percent }
\newlabel{fig:training}{{5}{11}{\textbf {Training Dynamics.} (A) Loss curves across training epochs showing convergence. (B) AUC progression during training. (C) Computational performance metrics.\relax }{figure.caption.8}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.4}Attention Analysis}{11}{subsection.3.4}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {6}{\ignorespaces \textbf  {Attention Analysis.} (A) Distribution of attention weights across sequences. (B) High-attention sequence characteristics. (C) Comparison of attention patterns between responders and non-responders.\relax }}{11}{figure.caption.9}\protected@file@percent }
\newlabel{fig:attention}{{6}{11}{\textbf {Attention Analysis.} (A) Distribution of attention weights across sequences. (B) High-attention sequence characteristics. (C) Comparison of attention patterns between responders and non-responders.\relax }{figure.caption.9}{}}
\@writefile{toc}{\contentsline {subsection}{\numberline {3.5}Gene Usage Patterns}{12}{subsection.3.5}\protected@file@percent }
\@writefile{lof}{\contentsline {figure}{\numberline {7}{\ignorespaces \textbf  {Gene Usage Patterns.} (A) V-gene usage frequency by response status. (B) J-gene usage frequency by response status. (C) V-J pairing preferences in responders vs. non-responders.\relax }}{12}{figure.caption.10}\protected@file@percent }
\newlabel{fig:gene_usage}{{7}{12}{\textbf {Gene Usage Patterns.} (A) V-gene usage frequency by response status. (B) J-gene usage frequency by response status. (C) V-J pairing preferences in responders vs. non-responders.\relax }{figure.caption.10}{}}
\@writefile{toc}{\contentsline {section}{\numberline {4}Discussion}{12}{section.4}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.1}Principal Findings}{12}{subsection.4.1}\protected@file@percent }
\citation{patel2015pd}
\citation{samstein2019tumor}
\citation{tumeh2014pd}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.2}Comparison with Existing Biomarkers}{13}{subsection.4.2}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.3}Biological Implications}{13}{subsection.4.3}\protected@file@percent }
\@writefile{toc}{\contentsline {subsection}{\numberline {4.4}Limitations}{13}{subsection.4.4}\protected@file@percent }
\citation{anthropic2025claudecode}
\citation{chen2021codex}
\citation{sidhom2021deeptcr}
\@writefile{toc}{\contentsline {subsection}{\numberline {4.5}Future Directions}{14}{subsection.4.5}\protected@file@percent }
\@writefile{toc}{\contentsline {section}{\numberline {5}Conclusion}{14}{section.5}\protected@file@percent }
\bibstyle{plainnat}
\bibdata{references}
\bibcite{anthropic2025claudecode}{{1}{2025}{{Anthropic}}{{}}}
\bibcite{bahdanau2015neural}{{2}{2015}{{Bahdanau et~al.}}{{Bahdanau, Cho, and Bengio}}}
\bibcite{bonilla2016genomic}{{3}{2016}{{Bonilla et~al.}}{{Bonilla, Parmentier, King, Bezrukov, Kber, Stuber, Letourneau, Sima, Radi, Pereira, et~al.}}}
\bibcite{chen2021codex}{{4}{2021}{{Chen et~al.}}{{Chen, Tworek, Jun, Yuan, de~Oliveira~Pinto, Kaplan, Edwards, Burda, Joseph, Brockman, et~al.}}}
\bibcite{dash2017quantifiable}{{5}{2017}{{Dash et~al.}}{{Dash, Fiore-Gartland, Hertz, Wang, Sharma, Souquette, Crawford, Clemens, Nguyen, Kedzierska, et~al.}}}
\bibcite{davis1988t}{{6}{1988}{{Davis and Bjorkman}}{{}}}
\bibcite{dietterich1997solving}{{7}{1997}{{Dietterich et~al.}}{{Dietterich, Lathrop, and Lozano-P{\'e}rez}}}
\bibcite{glanville2017identifying}{{8}{2017}{{Glanville et~al.}}{{Glanville, Huang, Nau, Hatton, Wagar, Rubelt, Ji, Han, Krams, Pettus, et~al.}}}
\bibcite{greiff2015bioinformatic}{{9}{2015}{{Greiff et~al.}}{{Greiff, Miho, Menzel, and Reddy}}}
\bibcite{ilse2018attention}{{10}{2018}{{Ilse et~al.}}{{Ilse, Tomczak, and Welling}}}
\bibcite{lecun2015deep}{{11}{2015}{{LeCun et~al.}}{{LeCun, Bengio, and Hinton}}}
\bibcite{mamedov2013preparing}{{12}{2013}{{Mamedov et~al.}}{{Mamedov, Britanova, Zvyagin, Turchaninova, Bolotin, Putintseva, Lebedev, and Chudakov}}}
\bibcite{migden2018pd}{{13}{2018}{{Migden et~al.}}{{Migden, Rischin, Schmults, Guminski, Hauschild, Lewis, Chung, Hernandez-Aya, Lim, Chang, et~al.}}}
\bibcite{patel2015pd}{{14}{2015}{{Patel and Kurzrock}}{{}}}
\bibcite{postow2015peripheral}{{15}{2015}{{Postow et~al.}}{{Postow, Manuel, Wong, Yuan, Dong, Liu, Perez, Tanneau, Noel, Courtier, et~al.}}}
\bibcite{ribas2018cancer}{{16}{2018}{{Ribas and Wolchok}}{{}}}
\bibcite{robins2009comprehensive}{{17}{2009}{{Robins et~al.}}{{Robins, Campregher, Srivastava, Wacher, Turtle, Kahsai, Riddell, Warren, and Carlson}}}
\bibcite{rossjohn2015t}{{18}{2015}{{Rossjohn et~al.}}{{Rossjohn, Gras, Miles, Turner, Godfrey, and McCluskey}}}
\bibcite{samstein2019tumor}{{19}{2019}{{Samstein et~al.}}{{Samstein, Lee, Shoushtari, Hellmann, Shen, Janjigian, Barron, Zehir, Jordan, Omuro, et~al.}}}
\bibcite{sharma2017primary}{{20}{2017}{{Sharma et~al.}}{{Sharma, Hu-Lieskovan, Wargo, and Ribas}}}
\bibcite{sidhom2021deeptcr}{{21}{2021}{{Sidhom et~al.}}{{Sidhom, Larman, Pardoll, and Baras}}}
\bibcite{stratigos2021european}{{22}{2020}{{Stratigos et~al.}}{{Stratigos, Garbe, Dessinioti, Lebbe, Bataille, Bastholt, Dreno, Fargnoli, Forsea, Frenard, et~al.}}}
\bibcite{topalian2015immune}{{23}{2015}{{Topalian et~al.}}{{Topalian, Drake, and Pardoll}}}
\bibcite{tumeh2014pd}{{24}{2014}{{Tumeh et~al.}}{{Tumeh, Harview, Yearley, Shintaku, Taylor, Robert, Chmielowski, Spasic, Henry, Ciobanu, et~al.}}}
\bibcite{vaswani2017attention}{{25}{2017}{{Vaswani et~al.}}{{Vaswani, Shazeer, Parmar, Uszkoreit, Jones, Gomez, Kaiser, and Polosukhin}}}
\bibcite{yarchoan2017tumor}{{26}{2017}{{Yarchoan et~al.}}{{Yarchoan, Hopkins, and Jaffee}}}
\bibcite{zhang2018investigation}{{27}{2020}{{Zhang et~al.}}{{Zhang, Ma, Schonnesen, Zhang, He, Sun, Williams, Jain, Bhattacharya, Fang-Landau, et~al.}}}
\@writefile{lof}{\contentsline {figure}{\numberline {8}{\ignorespaces \textbf  {Detailed AUC Analysis.} (A) Histogram of AUC values across 100 folds. (B) Box plot with individual fold values. (C) Fold-by-fold AUC stability analysis.\relax }}{19}{figure.caption.16}\protected@file@percent }
\newlabel{fig:s1}{{8}{19}{\textbf {Detailed AUC Analysis.} (A) Histogram of AUC values across 100 folds. (B) Box plot with individual fold values. (C) Fold-by-fold AUC stability analysis.\relax }{figure.caption.16}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {9}{\ignorespaces \textbf  {Per-Patient Analysis.} (A) Repertoire size by patient. (B) Prediction confidence by patient. (C) Attention weight distributions across patients.\relax }}{20}{figure.caption.18}\protected@file@percent }
\newlabel{fig:s2}{{9}{20}{\textbf {Per-Patient Analysis.} (A) Repertoire size by patient. (B) Prediction confidence by patient. (C) Attention weight distributions across patients.\relax }{figure.caption.18}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {10}{\ignorespaces \textbf  {J-Gene Usage Analysis.} (A) J-gene frequency comparison between responders and non-responders. (B) J-gene diversity metrics.\relax }}{20}{figure.caption.20}\protected@file@percent }
\newlabel{fig:s3}{{10}{20}{\textbf {J-Gene Usage Analysis.} (A) J-gene frequency comparison between responders and non-responders. (B) J-gene diversity metrics.\relax }{figure.caption.20}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {11}{\ignorespaces \textbf  {Computational Performance.} (A) Training time per fold. (B) GPU memory utilization. (C) Throughput analysis on H100 GPU.\relax }}{21}{figure.caption.22}\protected@file@percent }
\newlabel{fig:s4}{{11}{21}{\textbf {Computational Performance.} (A) Training time per fold. (B) GPU memory utilization. (C) Throughput analysis on H100 GPU.\relax }{figure.caption.22}{}}
\gdef \@abspage@last{21}
